scale. Yet the technology is the result of a long process of accumulation of innovation and capacity. It was a bumpy process …

This study seeks to provide evidence for deciding whether or not a pharmaceutical innovation should be included in the … treatment cost in both financing alternatives, justifying inclusion of the innovation in the benefit list from a cost …

; Innovation ; Pharmaceuticals ; Health care expenditure ; Cointegration … contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health …

This paper presents evidence of the effects of gender diversity on firm innovation outcomes and their productivity in … Colombian manufacturing firms, by extending a CDM model to include women’s participation in science, technology and innovation … endogeneity issues of women’s participation in STI and innovation behavior. An upward bias of the impact of gender diversity on …